The Musculoskeletal & Pain Management Division is dedicated to providing effective therapeutic solutions for the treatment of pain, inflammation, muscle spasms, and mobility-related disorders. The division aims to improve patient comfort, enhance physical function, and support a faster return to daily activities through high-quality pharmaceutical products.
Detailed Description
The Musculoskeletal & Pain Management Division focuses on developing, manufacturing, and supplying medicines that address a wide range of orthopedic, rheumatologic, neurological, and musculoskeletal conditions. Backed by GMP-certified manufacturing facilities and compliance with DRAP regulations and the Drug Licensing Management (DML) Rules 2019, the division ensures the highest standards of quality, safety, and efficacy.
Our product portfolio is designed to assist healthcare professionals in managing acute and chronic pain conditions, inflammatory disorders, muscle spasms, sports injuries, arthritis, and post-operative recovery. The division's therapies help reduce pain, relieve muscle stiffness, improve mobility, and enhance overall patient well-being.
The division includes muscle relaxants, analgesics, anti-inflammatory agents, and supportive therapies that provide effective symptom control while promoting recovery and rehabilitation. Through continuous commitment to innovation and quality, the division contributes to improving the quality of life for patients suffering from musculoskeletal disorders.
Main Products
- Thiocolchicoside Capsules/Tablets/Injection
- NSAIDs and Anti-inflammatory Medicines
- Analgesic Preparations
- Muscle Relaxants
- Arthritis and Joint Care Therapies
Featured Product – Thiocolchicoside
Thiocolchicoside is a centrally acting muscle relaxant indicated for the treatment of painful muscle spasms associated with orthopedic, rheumatologic, and neurological disorders. It helps relieve muscle stiffness, reduce pain, and improve mobility, supporting faster patient recovery and improved quality of life.